Call for papers - Immunity and inflammation in Cardiovascular Disorders

Vennela Boyalla: University of Manchester, UK

Dr Vennela Boyalla is an academic cardiology trainee in Manchester (United Kingdom). After graduating MBChB (MD) from University of Manchester, Vennela was appointed as an Academic Foundation Programme working on telemedicine trials in heart failure. She then gained Membership to the Royal College of Physicians (MRPC) during her internal medicine training. Following, Vennela worked as a PhD research fellow at Imperial College London running a multi-centre randomised controlled trial comparing ablation strategies in non-paroxysmal atrial fibrillation, which was funded by National Institute of Health Research (NIHR). She is now pursuing research interests in treating inflammation and obesity to help manage atrial fibrillation, while training in clinical cardiology. She has been appointed as Women in Cardiology trainee representative for Northwest England in the United Kingdom. During her spare time, she loves politics and cooking.
 

Enrique Gallego-Colon: Escuela Naval Militar (E.N.M.), Spain

Dr Enrique J. Gallego-Colon is a clinician and translational researcher in cardiology at Escuela Naval Militar (E.N.M.) and Associate Professor at Escuela Militar de Sanidad (EMISAN). For his PhD, he was awarded with a Marie Curie Early Stage Researcher, EU-FP7 to perform his Phd studies at the Imperial College London were he joined the cardiac regeneration group lead by Prof. Nadia Rosenthal. His main research interest is on cardiovascular health as well as the disease process development (atherosclerosis, stroke and myocardial infarction) with particular emphasis to the molecular mechanisms of cardiovascular immunity and regeneration. Especially interested on investigating novel therapeutic approaches to achieve functional recovery through enhancing the reparative processes of the of the damaged myocardium and reversal of adverse heart remodeling. His research overlaps with these clinical areas but also covers broad aspects of medicine and innovation. He is member of the European Society of Cardiology as well as the American Society of Cardiology.
 

Michael Spartalis: National and Kapodistrian University of Athens, Greece

Dr. Michael Spartalis is an Attending Cardiologist, Certified Electrophysiology Specialist, and Certified Cardiac Device Specialist. Currently, an Academic Scholar at the 3rd Department of Cardiology, National and Kapodistrian University of Athens, Clinical Scholar at Harvard Medical School, and an Expert on medical devices at the European Commission. His work focuses on cardiovascular medicine, cardiac electrophysiology, device therapy, and antiplatelet therapy. He currently works on evidence regarding the beneficial therapy with colchicine for atherosclerosis via anti-inflammation and decrease in hypertriglyceridemia. He holds an MD and a PhD from National and Kapodistrian University of Athens, Medical School, a MSc in Thrombosis, Hemorrhage and Transfusion medicine from National and Kapodistrian University of Athens, Medical School, a MHCM from Conservatoire National des Arts et Métiers, and a Master in Interventional Electrophysiology from Università Vita-Salute San Raffaele. Most recently, he completed the Oxford's Leadership Program.